Dr. Streja is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7345 Medical Center Dr
Suite 600
West Hills, CA 91307Phone+1 818-347-2921Fax+1 818-346-4436
Education & Training
Carol Davila University of Medicine and PharmacyClass of 1961
Certifications & Licensure
CA State Medical License 1979 - 2025- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) Start of enrollment: 2012 Jul 01
- A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- 65 citationsThe effects of prolonged fasting on plasma triglyceride kinetics in man.Dan Streja, E.B. Marliss, George Steiner
Metabolism. 1977-05-01 - 24 citationsNiacin and progression of CKD.Elani Streja, Csaba P. Kovesdy, Dan Streja, Hamid Moradi, Kamyar Kalantar-Zadeh
American Journal of Kidney Diseases. 2015-05-01 - 66 citationsFactors associated with implementation of preventive care measures in patients with diabetes mellitusDan Streja, Simon W. Rabkin
Archives of Internal Medicine. 1999-02-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
